Runx3, a tumor suppressor, is upregulated after miR-106b suppression, and the inhibition of Y79 cell proliferation is seen, which suggests that Runx3 is a target of miR-106b in an RB [116]. This evidence concerns the gene RUNX3 and retinoblastoma.